A. Aleksa

Comparison of effectiveness and safety of imipenem/clavulanate- versus meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB

Alimuddin Zumla, A. Spanevello, M. Gaga, 2016, European Respiratory Journal.

Effectiveness and Safety of Imipenem-Clavulanate Added to an Optimized Background Regimen (OBR) Versus OBR Control Regimens in the Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis.

Alimuddin Zumla, A. Spanevello, M. Gaga, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study

Alimuddin Zumla, K. Dheda, A. Spanevello, 2017, European Respiratory Journal.

Clinical standards for the dosing and management of TB drugs

D. van Soolingen, P. Denti, K. Dheda, 2022, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report

A. Spanevello, R. Duarte, D. Visca, 2019, European Respiratory Journal.

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study.

A. Spanevello, R. Duarte, E. Martínez Robles, 2019, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Faster for less: the new “shorter” regimen for multidrug-resistant tuberculosis

Alimuddin Zumla, M. Gaga, G. Sotgiu, 2016, European Respiratory Journal.

Safety and tolerability of clarithromycin in the treatment of multidrug-resistant tuberculosis

J. Kosterink, D. van Soolingen, Simon Tiberi, 2017, European Respiratory Journal.

Clinical standards for the management of adverse effects during treatment for TB

Shashank Srivastava, K. Dheda, S. Heysell, 2023, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort.

A. Spanevello, R. Duarte, E. Martínez Robles, 2021, Pulmonology.